Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hematoporphyrin monomethyl ether (HMME), a second-generation porphyrin-related photosensitizer, is a highly selective and low-toxicity compound known for its singular form and high yield of singlet oxygen. It finds extensive application in diagnosing and treating various tumors, including lung cancer, bladder cancer, nevus flammeus, and brain glioma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 92.00 |
Description | Hematoporphyrin monomethyl ether (HMME), a second-generation porphyrin-related photosensitizer, is a highly selective and low-toxicity compound known for its singular form and high yield of singlet oxygen. It finds extensive application in diagnosing and treating various tumors, including lung cancer, bladder cancer, nevus flammeus, and brain glioma. |
In vitro | Hematoporphyrin monomethyl ether (HMME), a new and promising porphyrin-based photosensitizer for photodynamic therapy (PDT), effectively induces cell death in HeLa cells through both necrosis and apoptosis. The production of reactive oxygen species (ROS), including singlet oxygen and hydroxyl radical in HeLa cells, is crucial for the success of HMME-PDT in triggering cell death[2]. |
Molecular Weight | 612.727 |
Formula | C35H40N4O6 |
CAS No. | 148471-91-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hematoporphyrin monomethyl ether 148471-91-4 inhibitor inhibit